ASTH

Astrana Health Stock Analysis

AI Rating

Neutral
  • Quality7/10
  • Growth 1/10
  • Value 5/10
Astrana Health sales and earnings growth
ASTH Growth
Low
  • Revenue Y/Y 58.52%
  • EPS Y/Y -16.22%
  • FCF Y/Y 197.39%
Astrana Health gross and profit margin trends
ASTH Profitability
Good
  • Gross margin 10.70%
  • EPS margin 0.90%
  • ROIC 5Y 19.00%
Astrana Health net debt vs free cash flow
ASTH Risk
Good
  • Debt / Equity 1.8
  • Debt / FCF 3.8
  • Interest coverage 1.8

Astrana Health stock is less volatile than the overall market, so it's low risk. We give it a Good risk rating.

↗ More Medical Care Facilities stocks